文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症心脑血管急症

体外膜肺氧合临床试验入组的性别差异

Sex Disparity in Extracorporeal Membrane Oxygenation Clinical Trial Enrollment.
PubMed 文献 · Crit Care Med · 2024-12-02
一句话结论2003–2023年发表的ECMO随机对照试验中女性仅占28%,ECPR与心源性休克VA-ECMO试验性别失衡最显著,限制试验结果对女性的适用性。

该横断面分析用Cochrane高敏感检索策略在PubMed检索2003–2023年发表的ECMO相关随机对照试验,最终纳入31项,其中28项报告了受试者性别数据。28项试验中26项(93%)入组男性多于女性,汇总女性占全部试验受试者的28%(95%CI 26-30%,551/1956例)。涉及体外心肺复苏(ECPR)的试验性别入组差异最大(男性83%),其次为心源性休克静脉-动脉ECMO试验(男性73%);影响因子≥10的期刊所发试验中男性占74%(95%CI 72-76%)。仅2项试验(7%)报告了受试者种族或民族数据。作者认为,女性相对于疾病患病率被低估在VA-ECMO治疗心源性休克和ECPR治疗心脏骤停的试验中最为显著,限制了这些试验结果对女性的适用性。

要点

  • 28项报告性别的ECMO随机对照试验中26项(93%)入组男性多于女性,汇总女性仅占28%(95%CI 26-30%,551/1956例)。
  • ECPR试验性别失衡最大(男性83%),其次为心源性休克VA-ECMO试验(男性73%)。
  • 影响因子≥10的期刊所发试验中男性占74%(95%CI 72-76%)。
  • 仅2项试验(7%)报告了受试者种族或民族数据。
  • 作者认为女性相对疾病患病率被低估在VA-ECMO心源性休克和ECPR心脏骤停试验中最显著,限制这些试验结果对女性的适用性。

适用人群与场景

  • 2003–2023年发表的随机对照试验,试验对象为测试ECMO作为治疗手段,或在接受ECMO的患者中测试其他干预。

研究设计与关键结果

  • 研究类型为横断面分析,检索PubMed获774篇文献,31项符合纳入标准,28项提供受试者性别数据。
  • 28项试验中26项(93%)入组男性多于女性,汇总女性占全部受试者的28%(95%CI 26-30%,551/1956例)。
  • ECPR试验性别入组差异最大(男性83%),其次为心源性休克VA-ECMO试验(男性73%)。
  • 影响因子≥10的期刊所发试验中男性占74%(95%CI 72-76%)。
  • 仅2项试验(7%)报告了受试者种族或民族数据。

证据类型、等级与局限

  • 证据类型:横断面分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,女性相对于疾病患病率被低估在VA-ECMO治疗心源性休克和ECPR治疗心脏骤停的试验中最为显著,限制了这些试验结果对女性的适用性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Multiple studies have shown that extracorporeal membrane oxygenation (ECMO) is used clinically more often in men than women. Because clinical trials provide the basis for identifying patients who are likely to benefit from medical therapies, we hypothesized that sex-based imbalances in ECMO trial enrollment may both reflect and perpetuate these observed disparities. Our objective was to determine whether sex-based enrollment imbalances exist within the published ECMO clinical trial literature.

DESIGN: Cross-sectional analysis.

SETTING: Randomized controlled trials published between 2003 and 2023 that either tested ECMO as a treatment modality or tested another intervention among patients receiving ECMO.

PATIENTS: Not applicable.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We used the Cochrane Highly Sensitive Search Strategy to search PubMed for eligible trials. Data on participant demographics, trial characteristics, and journal information were abstracted for each publication. The primary outcome of interest was the proportion of male and female participants in each published trial. The initial literature search identified 774 articles. Of these, 31 were eligible for inclusion, and 28 provided data on the sex of study participants. Twenty-six of these 28 trials (93%) enrolled more men than women, and in aggregate women comprised 28% (95% CI, 26-30%) of all trial participants (551/1956 subjects). Trials involving extracorporeal cardiopulmonary resuscitation (ECPR) exhibited the largest sex-based enrollment differences (83% men) followed by venoarterial ECMO for cardiogenic shock (73% men). Among trials published in journals with impact factors of ten or higher 74% (95% CI, 72-76%) of participants were men. Only two trials (7%) provided data on the race or ethnicity of study participants.

CONCLUSIONS: Substantial sex-based disparity exists in published ECMO clinical trials. Underrepresentation of women relative to disease prevalence is most significant among trials utilizing venoarterial ECMO for cardiogenic shock and ECPR for cardiac arrest, limiting the applicability of findings from these trials for women.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Damuth E, Baldwin C, Schmalbach N, et al. Sex Disparity in Extracorporeal Membrane Oxygenation Clinical Trial Enrollment. Crit Care Med. 2024. PMID: 39620867. doi:10.1097/CCM.0000000000006539

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。